Beta-Blocker Use and Outcomes Among Hospitalized Heart Failure Patients
Open Access
- 14 June 2006
- journal article
- Published by Elsevier
- Vol. 47 (12) , 2462-2469
- https://doi.org/10.1016/j.jacc.2006.03.030
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization EffectivenessJAMA, 2005
- Predischarge initiation of carvedilol in patients hospitalized for decompensated heart failure: results of the initiation management predischarge: process for assessment of carvedilol therapy in heart failure (impact-hf) trialACC Current Journal Review, 2004
- Outpatient utilization of angiotensin-converting enzyme inhibitors among heart failure patients after hospital dischargeJournal of the American College of Cardiology, 2004
- Predischarge initiation of carvedilol in patients hospitalized for decompensated heart failureJournal of the American College of Cardiology, 2004
- Clinical outcomes in patients on beta-blocker therapy admitted with worsening chronic heart failureThe American Journal of Cardiology, 2003
- Effect of Carvedilol on Survival in Severe Chronic Heart FailureNew England Journal of Medicine, 2001
- Beta‐blocker therapy in advanced heart failure: clinical characteristics and long‐term outcomesEuropean Journal of Heart Failure, 1999
- The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trialThe Lancet, 1999
- Carvedilol Produces Dose-Related Improvements in Left Ventricular Function and Survival in Subjects With Chronic Heart FailureCirculation, 1996
- The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart FailureNew England Journal of Medicine, 1996